Cases & Deals

  • Home
  • Practices
  • Special Committee of Board of Directors represented in response to shareholder demand letter arising out of FDA inspections

Share

Special Committee of Board of Directors represented in response to shareholder demand letter arising out of FDA inspections

November 2011

Client(s) Special Committee of the Board of Directors

Jones Day represented Special Committee of the Board of Directors in evaluating and recommending response to shareholder demand letter arising out of FDA inspections and related observations and communications concerning company operations.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.